BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

China M&A Management Holdings, Inc. Acquires 4.93% Of China Pharmaceuticals International Corporation


3/8/2006 12:12:45 PM

HONG KONG, March 8 /Xinhua-PRNewswire/ -- China Pharmaceuticals International Corporation , announced today the Company received notification from China M&A Management Holdings, Inc. ("CMA"), confirming purchases of 3,929,450 shares from the market, which is 4.93% of the Company's outstanding shares for US$0.15 per share.

Founded in 1997, CMA is a financial services company focusing on domestic and cross-border mergers and acquisitions. It also provides M&A related restructuring, corporate finance, corporate governance and IPO advisory services to its clients. CMA has over 30 professionals operating in four of China's most dynamic cities: Peking, Shanghai, Suzhou and Shenyang.

Globalization has dramatically increased the number of cross-border M&A transactions over the past decade and WTO accession has opened China's market further to foreign corporations seeking to grow their business in Asia's fast- growing economy. The demand for M&A advisory services focusing on the China's market is rising dramatically in the anticipation of greatly increased business opportunities. With high recognition, CMA has strategically internationalized our services based on the concrete achievement of previous years.

CMA's dedicated specialists provide its clients the most innovative and customized M&A, financial and corporate restructuring solutions coupled with the latest news, research and analysis on the Chinese M&A market. CMA always works closely with our clients, listed or unlisted, state-owned or private enterprises, to meet their individual needs and to fit the unique Chinese marketplace.

Contact: China Pharmaceuticals International Corporation Sifie Fu, Investor Relations Manager Tel: +852-2255-0688 Email: sifiefu@DiChain.com Investor Relations Email: Investors@DiChain.com Website: http://www.chinapharmacorp.com/

China Pharmaceuticals International Corporation

CONTACT: Sifie Fu, Investor Relations Manager of China PharmaceuticalsInternational Corporation, +852-2255-0688, sifiefu@DiChain.com, InvestorRelations - Investors@DiChain.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES